Substantial cost savings with SC rituximab in DLBCL

June 2017, Volume 780, Issue 1, pp 35–35 | Cite as

Clinical study

First Online: 17 June 2017

This is a preview of subscription content, to check access.

Reference

Mihajlovic J, et al. Microcosting Study of Rituximab Subcutaneous Injection Versus Intravenous Infusion. Clinical Therapeutics : 1 Jun 2017Google Scholar

Cite this article as:: PharmacoEcon Outcomes News (2017) 780: 35. https://doi.org/10.1007/s40274-017-4087-4

Get Access to

PharmacoEconomics & Outcomes News

for the whole of 2018